News about Biotechnology, Pharmaceutical and Healthcare

03:18 EST 6th December 2016 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 29,000+

Monday 5th December 2016

McKesson's Pharmacy Optimization team identifies 5 key pharmacy trends headed into 2017

Michael JohnsenIn an effort to contain costs and both improve and expand care, pharmacists will more and more play an integral role in healthcare, as illustrated by these five key trends identified by McKesson analysts. read more

Wakefern elevates veteran Chris Lane to EVP

Gina AcostaWakefern Food Corp. has promoted a 13-year veteran of the company to executive vice president, overseeing day-to-day operations and strategy planning. read more

Walmart tests convenience-store format with online grocery pickup service

Marianne WilsonWalmart has opened a 4,000-sq.-ft. format that offers pick-up of online grocery orders and a convenience store that also sells snacks, beverages and more.      read more

4 trends: The future of sales

Dan MackThe future of sales is both on us today and will continue to evolve at warp speed, writes Dan Mack in his new column. Hyper-competition is squeezing flexibility and demanding a new sales approach. And tomorrow’s sales leaders must possess the holistic business skills of a general manager.

VoicePort partners with iMedicare

David SalazarWith the partnership, VoicePort customers can access iMedicare’s analyses to help patients make the best decisions when choosing a Medicare Advantage or prescription drug plan.  read more

FDA Office of New Drugs director Jenkins to retire

David Salazar The Food and Drug Administration’s director of the Center for Drug Evaluation and Research, Dr. Janet Woodcock, said that the agency would conduct a national search to fill the vacancy left by retiring Office of New Drugs director Dr. John Jenkins, and that in the interim, she would be acting director of the OND. read more

CHPA adds seasoned executive to government affairs team

Michael JohnsenSchloss is an experienced and accomplished executive with two decades of experience in federal government affairs, most recently at Mylan helping direct their Congressional outreach efforts. read more

NACDS praises Congressional support behind TRICARE pilot program

Michael JohnsenThe U.S. House of Representatives passed the final NDAA Friday – as negotiated between the House and Senate. Senate action is anticipated soon. read more

US bill that heralds reform of drug approval process passed by House of Representatives

A landmark US law that would boost funding for medical research, mental health and substance misuse services and speed up drug and medical device approval has passed its latest legislative hurdle.

Q&A: From pharmacy to the Scottish Parliament — interview with MSP Maree Todd

Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.

Target celebrates 20-year St. Jude's partnership with Bullseye Bash

Gina AcostaTarget is celebrating 20 years of partnership efforts with St. Jude Children’s Research Hospital, which helps save the lives of children battling cancer and other life-threatening diseases.  read more

Boehringer Ingelheim’s, Lilly's Jardiance gets new indication

The Food and Drug Administration has approved the drug as a treatment to reduce risk of cardiovascular death in patients with Type 2 diabetes.  read more

NHS England to trial pre-exposure prophylaxis for HIV prevention before full roll-out

NHS England has announced it will fund a large-scale clinical trial on the use of pre-exposure prophylaxis (PrEP) for the prevention of HIV ahead of a national roll-out.

Boulder Canyon pushes the better-for-you envelope with new snacks

Gina AcostaBoulder Canyon Authentic Foods is introducing three new gluten-free snack crisps made with an array of better-for-you ingredients. read more

For National Influenza Vaccination Week, Rite Aid offers $5 flu shot discount

Michael JohnsenRite Aid's Vaccine Central, an assessment tool where visitors can complete a personal immunization evaluation, is an additional resource for people to further review immunization recommendations. read more

Automated pharmacy notifications can make the difference in advance of natural disasters

Brian BerkStudy reveals that patients who received such outreach are 9% more likely to refill medications within 48 hours. read more

Dr. Reddy’s launches nystatin/triamcinolone acetonide cream

David Salazar The drug had $119 million in sales for the 12 months ended October 2016, according to QuintilesIMS data.

NICE recommends HIV testing in community pharmacy to cut number of undiagnosed cases

New guideline recommends that HIV testing should be available in community settings, the voluntary sector and venues where there may be high-risk sexual behaviour.

Map of all medicines and their mode of action is created

Scientists have mapped all 1,578 licensed drugs licensed by the US Food and Drug Administration according to their mechanisms of action to help researchers visualise the ‘uncharted waters’ where they may find future treatments.

Deaths: David Friend

On 10 November 2016, David Friend FRPharmS, aged 82, of Macclesfield, Cheshire. Mr Friend registered with the Society in 2010 and was designated a Fellow in 1987. Mr Friend was chief executive of Zeneca Pharmaceuticals from 1987, when it was still part of Imperial Chemical Industries (ICI), until his retirement in 1994. He was also president of the European Federation of Pharmaceutical Industry As...

Record number of Fortune 500 Cos. score '100' on 2017 Corporate Equality Index

Michael JohnsenThis year, a record-breaking 517 businesses earned the CEI’s top score of 100, up from 407 last year. read more

Xenetic Biosciences Expands Management Team with Key Appointment of Jeffrey F. Eisenberg as Chief Operating Officer

Monday, December 5th 2016 at 12:05pm UTC LEXINGTON, Mass.–(BUSINESS WIRE)– Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics, announced today it has appointed Jeffrey F. Eisenberg as Chief Oper...

Celltrion Healthcare présente des résultats positifs pour le CT-P10 (candidat biosimilaire du rituximab), administré à des patients atteints d’un lymphome folliculaire à un stade avancé nouvellement diagnostiqué

Monday, December 5th 2016 at 2:03pm UTC Une étude pivot montre l’équivalence en matière de pharmacocinétique et de données d’innocuité entre le CT-P10 et le rituximab de référence SAN DIEGO–(BUSINESS WIRE)– De nouveaux résultats présentés à l’occasion du congrès annuel 2016 de l’American Society of Hematology (ASH) démontrent que le CT-P10 (candidat biosimilaire d...

Mersana Presents Updated Data on Investigational Cancer Antibody Drug Conjugate at World Conference on Lung Cancer

Monday, December 5th 2016 at 12:00pm UTC XMT-1536 Demonstrates Anti-tumor Activity in Lung Cancer Patient-Derived Xenograft Studies CAMBRIDGE, Mass.–(BUSINESS WIRE)– Mersana Therapeutics, Inc., a biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Fleximer® platform technology, today announced that it presented data on...

KYOCERA Medical Corporation Receives FDA 510(k) Clearance for Initia® Total Hip System, Featuring BIOCERAM AZUL® Ceramic Femoral Head

Monday, December 5th 2016 at 1:05pm UTC SAN DIEGO–(BUSINESS WIRE)– Kyocera Medical Corporation, a leading manufacturer of implantable systems and advanced ceramic components, today announced it has received the U.S. Food and Drug Administration’s 510(k) clearance for its Initia® Total Hip System. Developed in collaboration with leading U.S. surgeons, the Initia Total Hip System feat...

Quick Search